Interaction of angiotensin II and nitric oxide in isolated perfused afferent arterioles of mice

Journal of the American Society of Nephrology

Volumn 12, Issue 6, 2001, Pages 1122-1127

  Patzak, Andreas ^a,c   Mrowka, Ralf ^a   Storch, Eberhard ^a   Hocher, Berthold ^a,b   Persson, Pontus B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; FEMALE; MALE; MOUSE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0034998447     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Baumann JE, Persson PB, Ehmke H, Nafz B, Kirchheim HR: Role of endothelium-derived relaxing factor in renal autoregulation in conscious dogs. Am J Physiol 263: F208-F213, 1992
2. Chin SY, Wang CT, Majid DS, Navar LG: Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat. Am J Physiol 274: F876-F882, 1998
3. Navar LG, Ichihara A, Chin SY, Imig JD: Nitric oxide-angiotensin II interactions in angiotensin II-dependent hypertension. Acta Physiol Scand 168: 139-147, 2000
4. Boulanger CM, Caputo L, Levy BI: Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension 26: 752-757, 1995
5. Siragy HM, Carey RM: The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′, 5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest 97: 1978-1982, 1996
6. Ito S, Johnson CS, Carretero OA: Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 87: 1656-1663, 1991
7. Stauss HM, Godecke A, Mrowka R, Schrader J, Persson PB: Enhanced blood pressure variability in eNOS knockout mice. Hypertension 33: 1359-1363, 1999
8. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O: Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93: 13,176-13,181, 1996
9. Ohashi Y, Kawashima S, Hirata K, Yamashita T, Ishida T, Inoue N, Sakoda T, Kurihara H, Yazaki Y, Yokoyama M: Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest 102: 2061-2071, 1998
10. Brosnihan KB, Li P, Ganten D, Ferrario CM: Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am J Physiol 273: R1908-R1915, 1997
11. Nickenig G, Baumer AT, Grohe C, Kahlert S, Strehlow K, Rosenkranz S, Stablein A, Beckers F, Smits JF, Daemen MJ, Vetter H, Bohm M: Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97: 2197-2201, 1998
12. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, Couse JF, Curtis SW, Korach KS: Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 99: 2429-2437, 1997
13. Baylis C, Harton P, Engels K: Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1: 875-881, 1990
14. Sandner P, Kornfeld M, Ruan X, Arendshorst WJ, Kurtz A: Nitric oxide/cAMP interactions in the control of rat renal vascular resistance. Circ Res 84: 186-192, 1999
15. De Nicola L, Blantz RC, Gabbai FB: Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat. J Clin Invest 89: 1248-1256, 1992
16. King AJ, Troy JL, Anderson S, Neuringer JR, Gunning M, Brenner BM: Nitric oxide: A potential mediator of amino acid-induced renal hyperemia and hyperfiltration. J Am Soc Nephrol 1: 1271-1277, 1991
17. Klahr S: Can L-arginine manipulation reduce renal disease? Semin Nephrol 19: 304-309, 1999
18. Kohagura K, Endo Y, Ito O, Arima S, Omata K, Ito S: Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole. Acta Physiol Scand 168: 107-112, 2000
19. Parekh N, Dobrowolski L, Zou AP, Steinhausen M: Nitric oxide modulates angiotensin II-and norepinephrine-dependent vasoconstriction in rat kidney. Am J Physiol 270: R630-R635, 1996
20. Ichihara A, Imig JD, Inscho EW, Navar LG: Interactive nitric oxide-angiotensin II influences on renal microcirculation in angiotensin II-induced hypertension. Hypertension 31: 1255-1260, 1998
21. Ikenaga H, Fallet RW, Carmines PK: Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANG II in rat kidney. Am J Physiol 271: F365-F373, 1996
22. Sigmon DH, Beierwaltes WH: Angiotensin II: Nitric oxide interaction and the distribution of blood flow. Am J Physiol 265: R1276-R1283, 1993
23. Pueyo ME, Arnal JF, Rami J, Michel JB: Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol 274: C214-C220, 1998
24. Siragy HM, Carey RM: The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100: 264-269, 1997
25. Star RA: Intrarenal localization of nitric oxide synthase isoforms and soluble guanylyl cyclase. Clin Exp Pharmacol Physiol 24: 607-610, 1997
26. Mundel P, Bachmann S, Bader M, Fischer A, Kummer W, Mayer B, Kriz W: Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int 42: 1017-1019, 1992
27. Kone BC, Baylis C: Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 272: F561-F578, 1997
28. Millatt LJ, Abdel-Rahman EM, Siragy HM: Angiotensin II and nitric oxide: A question of balance. Regul Pept 81: 1-10, 1999